This agreement makes it the first of its kind on the African continent.

Biovac Institute will manufacture the Covid-19 vaccine at their plant in Cape Town, according toFin24.

Biovac is expected to produce more than 100 million doses per year once it is up and operating.

Pfizer, BioNTech, Biovac, Manufacture, Cape Town, Vaccine Deal, 100 Million Vaccines, Produced in South Africa

South African company Biovac has signed a contract with BioTech and Pfizer to manufacture Covid-19 vaccines locally. Image: Mujahid Safodien/AFPSource: Getty Images

The vaccines will be distributed to 55 countries under the African Union.

Biovac chief executive officer Morena Makhoana stated this move will enhance the long-term accessibility of vaccines on the continent.

Enjoyed reading our story?

Article image

Read also

Download BRIEFLY’s news app onGoogle Playnow and stay up-to-date with major South African news!

Source: Briefly News

Lebogang Mashego (Current Affairs HOD)Lebogang Mashego runs the Current Affairs desk.

She joined the Briefly News team in 2021.

Article image

Read also

She has 6 years of experience in the journalism field.

She worked as a lifestyle writer and editor at W24 and Opera News.

She graduated with a BA degree majoring in Journalism and Media Studies in 2017.

She’s a recipient of the INMA Elevate Scholarship.

Email: lebogang.mashego@briefly.co.za